Financials
- Market Capitalization 719.98 M
- Employee 102
- Founded 2010
- CEO Brian Stuglik
- Website www.verastem.com
- Headquarter Massachusetts, United States
- FIGI BBG001J2LSK5
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2.56
Fiyat/satışlar oranı
17.31
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2607 | ACHV Achieve Life Sciences, Inc. - Common Shares | 7.05 USD | -0.14% | -2.08% | -0.14% | +129.64% | 725.46 M USD | ||
| 2612 | LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 1.62 USD | -1.82% | -7.43% | -18.18% | +12.50% | 720.83 M USD | ||
| 2617 | CADL Candel Therapeutics, Inc. - Common Stock | 9.34 USD | -4.50% | -8.34% | -10.28% | +47.09% | 714.68 M USD | ||
| 2635 | FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 12.52 USD | -3.69% | -2.95% | -8.21% | +10.80% | 691.66 M USD |